These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7904561

  • 21. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
    Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC.
    Eur J Nucl Med; 1993 Aug; 20(8):716-31. PubMed ID: 8404961
    [Abstract] [Full Text] [Related]

  • 22. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man.
    Bakker WH, Krenning EP, Breeman WA, Kooij PP, Reubi JC, Koper JW, de Jong M, Laméris JS, Visser TJ, Lamberts SW.
    J Nucl Med; 1991 Jun; 32(6):1184-9. PubMed ID: 1646302
    [Abstract] [Full Text] [Related]

  • 23. Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
    Lamberts SW, Reubi JC, Bakker WH, Krenning EP.
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():20-1. PubMed ID: 1980773
    [Abstract] [Full Text] [Related]

  • 24. Intraoperative detection and resection of occult neuroblastoma: a technique exploiting somatostatin receptor expression.
    Martinez DA, O'Dorisio MS, O'Dorisio TM, Qualman SJ, Caniano DA, Teich S, Besner GE, King DR.
    J Pediatr Surg; 1995 Nov; 30(11):1580-9. PubMed ID: 8583329
    [Abstract] [Full Text] [Related]

  • 25. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
    De Jong M, Breeman WA, Bernard HF, Kooij PP, Slooter GD, Van Eijck CH, Kwekkeboom DJ, Valkema R, Mäcke HR, Krenning EP.
    Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786
    [Abstract] [Full Text] [Related]

  • 26. [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.
    Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP.
    Eur J Nucl Med; 2001 Sep; 28(9):1319-25. PubMed ID: 11585290
    [Abstract] [Full Text] [Related]

  • 27. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.
    Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausema L, Lameris JS, Reubi JC, Lamberts SW.
    Lancet; 1989 Feb 04; 1(8632):242-4. PubMed ID: 2563413
    [Abstract] [Full Text] [Related]

  • 28. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
    Faglia G, Bazzoni N, Spada A, Arosio M, Ambrosi B, Spinelli F, Sara R, Bonino C, Lunghi F.
    J Clin Endocrinol Metab; 1991 Oct 04; 73(4):850-6. PubMed ID: 1653785
    [Abstract] [Full Text] [Related]

  • 29. [99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results.
    Maina T, Nock B, Nikolopoulou A, Sotiriou P, Loudos G, Maintas D, Cordopatis P, Chiotellis E.
    Eur J Nucl Med Mol Imaging; 2002 Jun 04; 29(6):742-53. PubMed ID: 12029547
    [Abstract] [Full Text] [Related]

  • 30. Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.
    Breeman WA, de Jong M, Bernard B, Hofland LJ, Srinivasan A, van der Pluijm M, Bakker WH, Visser TJ, Krenning EP.
    Anticancer Res; 1998 Jun 04; 18(1A):83-9. PubMed ID: 9568060
    [Abstract] [Full Text] [Related]

  • 31. [177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
    de Jong M, Breeman WA, Bernard BF, Bakker WH, Schaar M, van Gameren A, Bugaj JE, Erion J, Schmidt M, Srinivasan A, Krenning EP.
    Int J Cancer; 2001 Jun 01; 92(5):628-33. PubMed ID: 11340564
    [Abstract] [Full Text] [Related]

  • 32. [123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide.
    Stahl A, Meisetschläger G, Schottelius M, Bruus-Jensen K, Wolf I, Scheidhauer K, Schwaiger M.
    Eur J Nucl Med Mol Imaging; 2006 Jan 01; 33(1):45-52. PubMed ID: 16151771
    [Abstract] [Full Text] [Related]

  • 33. Somatostatin-receptor imaging in the localization of endocrine tumors.
    Lamberts SW, Bakker WH, Reubi JC, Krenning EP.
    N Engl J Med; 1990 Nov 01; 323(18):1246-9. PubMed ID: 2170840
    [Abstract] [Full Text] [Related]

  • 34. Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imaging.
    Erfani M, Shafiei M, Mazidi M, Goudarzi M.
    Cancer Biother Radiopharm; 2013 Apr 01; 28(3):240-7. PubMed ID: 23464855
    [Abstract] [Full Text] [Related]

  • 35. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
    Krenning EP, Kwekkeboom DJ, Oei HY, Reubi JC, van Hagen PM, Kooij PP, Reijs AE, Lamberts SW.
    Schweiz Med Wochenschr; 1992 Apr 25; 122(17):634-7. PubMed ID: 1350377
    [Abstract] [Full Text] [Related]

  • 36. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
    Becker W, Marienhagen J, Scheubel R, Saptogino A, Bakker WH, Breeman WA, Wolf F.
    Eur J Nucl Med; 1991 Apr 25; 18(11):924-7. PubMed ID: 1684323
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pituitary imaging using a labelled somatostatin analogue in acromegaly.
    Ur E, Mather SJ, Bomanji J, Ellison D, Britton KE, Grossman AB, Wass JA, Besser GM.
    Clin Endocrinol (Oxf); 1992 Feb 25; 36(2):147-50. PubMed ID: 1348978
    [Abstract] [Full Text] [Related]

  • 39. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
    Hofland LJ, van Koetsveld PM, Waaijers M, Zuyderwijk J, Breeman WA, Lamberts SW.
    Endocrinology; 1995 Sep 25; 136(9):3698-706. PubMed ID: 7649075
    [Abstract] [Full Text] [Related]

  • 40. Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
    Bernard BF, Krenning E, Breeman WA, Visser TJ, Bakker WH, Srinivasan A, de Jong M.
    Nucl Med Commun; 2000 Nov 25; 21(11):1079-85. PubMed ID: 11192715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.